Julianne McGlynn, MD is a third year general pediatrics resident at the Children’s Hospital of Philadelphia and is thrilled to be staying at CHOP next year for pulmonary fellowship. She received her undergraduate degree from the University of Notre Dame and attended Sidney Kimmel Medical College at Thomas Jefferson University for medical school before coming to CHOP. Julianne developed an interest in pulmonary medicine during residency, enjoying the opportunity to merge outpatient continuity with helping to care children in intensive care units. This led her to a clinical interest in long term outcomes in children with bronchopulmonary dysplasia. In partnership with her outstanding mentor, Dr. Sharon McGrath-Morrow, Julianne investigated identifying risk factors that will help outpatient pulmonologists determine which children with bronchopulmonary dysplasia are more vulnerable and require closer monitoring after initial hospital discharge.
Learning Objectives:
- List proposed mechanisms for airflow obstruction in preterm infants with bronchopulmonary dysplasia and if family history of asthma is a risk factor
- Discuss if family history of asthma is associated with any demographic or clinical characteristics in children with bronchopulmonary dysplasia
- Identify if family history of asthma is a risk factor for higher acute care usage or chronic symptoms in children with bronchopulmonary dysplasia within the first 3 years of life following initial discharge home
Speaker:
- Julianne McGlynn, MD
This seminar was delivered as a Pediatric Grand Rounds Lecture at Children’s Hospital of Philadelphia, on May 25, 2022.
Content Disclaimer
The Terms of Use and Privacy Policy set forth on the website of The Children’s Hospital of Philadelphia apply to any and all uses of and access to this site and the content found here.
The work presented in the presentations, videos, and other content on this site (“Presentations”) includes publicly available medical evidence, a consensus of medical practitioners, and/or opinions of individual practitioners that may differ from consensus opinions. These Presentations are intended only to provide general information and need to be adapted for each specific patient based on the practitioner’s professional judgment, consideration of any unique circumstances, the needs of each patient and their family, the availability of various resources at the health care institution where the patient is located, and other factors. The Presentations are not intended to constitute medical advice or treatment, nor should they be relied upon as such. The Presentations are not intended to create a doctor-patient relationship between/among The Children’s Hospital of Philadelphia, its physicians and the individual patients in question. The information contained in these Presentations are general in nature, and do not and are not intended to refer to specific patients.
CHOP, The Children’s Hospital of Philadelphia Foundation and its or their affiliates, the authors, presenters, practitioners, editors, and others associated with the creation of the Presentations (“CHOP”) are not responsible for errors or omissions in the Presentations; for any outcomes a patient might experience where a clinician reviewed one or more such Presentations in connection with providing care for that patient; and/or for any and all third party content on the site or in the Presentations. CHOP makes no warranty, expressed or implied, with respect to the currency, completeness, applicability or accuracy of the Presentations. Application of the information in or to a particular situation remains the professional responsibility of the practitioner who is directly treating the patient.
To the extent that the Presentations include information regarding drug dosing, in view of ongoing research, changes in government regulations and the constant flow of information relating to drug therapy and drug reactions, the viewer should not rely on the Presentation content, but rather is urged to check the package insert for each drug for indications, dosage, warnings and precautions.
Some drugs and medical devices presented in the Presentations have United States Food and Drug Administration (FDA) clearance for limited use in restricted research settings. It is the responsibility of the practitioner to ascertain the FDA status of each drug or device planned for use in their clinical practice.
You shall indemnify, defend and hold harmless CHOP, The Children’s Hospital of Philadelphia Foundation, and its/their current and former employees, officers, and agents, trustees, and their respective successors, heirs and assigns (“Indemnitees”) against any claims, liability, damage, loss or expenses (including attorneys’ fees and expenses of litigation) in connection with any claims, suits, actions, demands or judgments arising directly or indirectly out of your reference to or use of the Presentations.
The Presentations are protected by copyright laws and in some cases patent laws, and all rights are reserved under such laws. No part of the Presentations may be reproduced in any form by any means, or utilized in any other way, absent prior written permission from the copyright owner.
By starting this module, you agree to our Content Disclaimer and Terms of Service.
Course Includes
- 1 Lesson
- Course Certificate